Alternating, intravenous administration of two replicating arenaviral vectors induce tumor-specific responses exceeding 50% of the circulating CD8 T cells 2-vector approach resulted in tumor cures and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback